Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

Historical Holders from Q3 2023 to Q4 2024

Symbol
ACST
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
15.5M
All holders as of 31 Dec 2024
Q4 2024
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-11
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.9% -0.9% 1.53M +2.14% ADAR1 Capital Management GP, LLC 30 Sep 2025

Institutional Holders of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 0 $0 -$3.48M 0
2024 Q3 1.16M $3.48M -$2.9M $3.00 11
2024 Q2 2.15M $6.3M +$2.59M $2.93 12
2024 Q1 1.27M $4.34M +$2.38M $3.43 10
2023 Q4 571K $1.65M -$144K $2.89 9
2023 Q3 558K $1.55M +$1.55M $2.78 10